Lowilius Wiyono

Mr. Lowilius Wiyono

University of Indonesia, Depok, Jawa Barat, Indonesia
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2021 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
ASAnita Dominique Subali
Anita Dominique Subali
LWLowilius Wiyono
Lowilius Wiyono
MYMuhammad Yusuf
Muhammad Yusuf
MZMuhammad Fathi Athallah Zaky
Muhammad Fathi Athallah Zaky

16 September 2021 in Epidemiology and Health
Verified
Journal Article
Open access
PDF file
LWLowilius Wiyono
Lowilius Wiyono
IRIan Christopher N. Rocha
Ian Christopher N. Rocha
TCTrisha Denise D. Cedeño
Trisha Denise D. Cedeño
AMAdriana Viola Miranda
Adriana Viola Miranda
DIDon Eliseo Lucero-Prisno III
Don Eliseo Lucero-Prisno III
Member countries of the Association of Southeast Asian Nations (ASEAN) have faced dengue outbreaks for decades, and the region has one of the highest rates of dengue globally. Outbreaks continue to occur concurrently with the coronavirus disease 2019 (COVID-19) pandemic in the 10 ASEAN countries. Both infectious diseases pose a tremendous burden in these countries related to both infection control and the economy. Increases in the number of dengue cases occurred in part due to disruptions in the pathogen-host-vector relationship caused by changes in human behaviour in response to the COVID-19 pandemic. The spread of dengue was further aggravated by the implementation of lockdowns and social distancing policies. These measures limited the coverage of dengue preventive programs and delayed the medical management of both diseases due to co-infection and misdiagnosis. It is of the utmost importance for the population to remain aware of both diseases, and dengue vector control strategies must be devised to properly address outbreaks using digitalization and remote surveillance. Similarly, critical triage algorithms and further research are also needed to combat co-infection and misdiagnosis. Controlling the spread of COVID-19 though vaccination should also be undertaken to reduce the impact of the pandemic.

4 June 2021 in Pathogens and Global Health
Verified
Journal Article
Closed access
ASAnita Dominique Subali
Anita Dominique Subali
LWLowilius Wiyono
Lowilius Wiyono
COVID-19 pandemic has become a global public health priority. The rapid increase in infection numbers, along with a significant number of deaths, has made the virus a serious threat to human health. Rapid, reliable, and simple diagnostic methods are critical to controlling the disease. While Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is the current diagnostic gold standard, Reverse Transcriptase Loop-Mediated Isothermal Amplification (RT-LAMP) appears to be a compelling alternative diagnostic test due to its greater simplicity, shorter time to obtain a result, and lower cost. This study examined RT-LAMP application for rapid identification of SARS-CoV-2 infection compared to the RT-PCR assay. A systematic review and meta-analysis was conducted over six scientific databases in accordance with PRISMA guidelines. Original studies published in English conducted on human clinical samples were included. Articles evaluating the sensitivity and specificity of RT-LAMP relative to RT-PCR were considered eligible. Quality assessment of bias and applicability was examined based on QUADAS-2. A total of 351 studies were found based on the keywords and search queries. Fourteen eligible case–control studies fit the mentioned criteria. Quality assessment using QUADAS-2 indicated alow risk of bias for all included studies. All case studies, containing 2,112 samples, had acumulative sensitivity of 95.5% (CI 97.5% = 90.8–97.9%) and cumulative specificity of 99.5% (CI 97.5% = 97.7–99.9%). The RT-LAMP assay could be areliable alternative COVID-19 diagnostic method due to its reduced cost and processing time compared to RT-PCR. RT-LAMP could potentially be utilized during critical high-throughput and high-demand situations.

1 January 2020 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
PDF file
LWLowilius Wiyono
Lowilius Wiyono
BEBrenda Cristie Edina
Brenda Cristie Edina
RRRisya Amelia Rahmawanti
Risya Amelia Rahmawanti
NANurma Nur Azizah
Nurma Nur Azizah
RPRafika Indah Paramita
Rafika Indah Paramita
DFDila Fadilah
Dila Fadilah
Breast cancer is the 3rd most common cancer in the world and the most common one in women. An alternative pharmacological treatment for breast cancer is needed. Kaempferia pandurata is an endemic plant in Asia which is known for its biological activity, of which is an anticancer activity with its most abundant bioactive compound, pinostrobin. The rhizome of Kaempferia pandurata is dried and extracted using maseration with n-Hexane solvent. The extract then isolated using the recrystallization method in methanol solvent to produce pinostrobin crystal. Pinostrobin is manufactured into nanoparticle using chitosan and sodium alginate polymer, which then analyzed using TEM and UV-Vis test. The pinostrobin and its nanoparticle counterpart are tested in MTT assay to show its inhibitory activity and then analyzed. TEM and UV-Vis test to the nanoparticle of pinostrobin showed the nanoparticle's dimension of <200 nm with a yield of 99.43%. MTT assay showed good anticancer activity from both pinostrobin and its nanoparticle. Better activity is shown by MDAMB-231 cell, while nanoparticle of pinostrobin showed better activity. The nanoparticle of pinostrobin has been manufactured with a decent yield and dimension. Better anticancer activity is shown in pinostrobin nanoparticle while the anticancer activity of MDAMB-231 cell is superior to MCF-7 cell for both samples. Pinostrobin can be considered as a potential drug for breast cancer.

30 September 2023 in Annals of Pediatric Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
LWLowilius Wiyono
Lowilius Wiyono
NGNida Ghitha
Nida Ghitha
DCDina Clarisa
Dina Clarisa
ALAnjani Larasati
Anjani Larasati
Purpose: Type 1 diabetes mellitus, which is the most common type of diabetes among children, is not curable but can be managed well without a negative effect on quality of life. One of the treatments of type 1 diabetes mellitus is carbohydrate counting. This systematic review and meta-analysis sought to evaluate the efficacy of carbohydrate counting with regard to hemoglobin A1c (HbA1c) reduction in children with type 1 diabetes mellitus.Methods: Nine studies were assessed, with the primary outcome being glycemic control (HbA1c changes). We searched the following electronic databases: ProQuest, PubMed, Scopus, and ScienceDirect. The quality of studies included was assessed using the risk of bias for randomized control trials and the JBI Critical Appraisal Checklist for observational and cross-sectional studies. Quantitative analyses were made and extrapolated into a forest plot.Results: A total of 1,693 articles were identified. Four reviewers independently screened titles and abstracts. Of the 36 articles screened, 34 articles were found to be eligible. Of these, 25 studies were excluded because of unsuitable outcomes and study designs. Nine articles were included in the final analysis. Meta-analysis showed that there was a reduction in HbA1c in the carbohydrate counting group as compared to the control group. The cumulative effect of carbohydrate counting on HbA1c was a mean difference of -0.55 (95% confidence interval, -0.81 to -0.28, P<0.001). All of the studies exhibited similar results with the mean difference reduction favoring the interventional group. However, the heterogeneity analysis revealed an I2 value of 88%, implying high heterogeneity in the meta-analysis.Conclusion: The meta-analysis showed evidence favoring the use of carbohydrate counting in the management of type 1 diabetes mellitus.

10 September 2021 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
PDF file
AMAdriana Viola Miranda
Adriana Viola Miranda
LWLowilius Wiyono
Lowilius Wiyono
IRIan Christopher N. Rocha
Ian Christopher N. Rocha
TCTrisha Denise D. Cedeño
Trisha Denise D. Cedeño
DIDon Eliseo Lucero-Prisno III
Don Eliseo Lucero-Prisno III
: The Association of Southeast Asian Nations (ASEAN) region is known to be a global hotspot to viral outbreaks because of many factors. To limit the impact of future outbreaks, it is crucial for the ASEAN governments to strengthen regional virology research capacity. The ASEAN governments have collaborated in several virology initiatives, with the most recent being the establishment of the ASEAN Regional Center for Public Health Emergencies and Emerging Diseases. However, several challenges, including technology disparities, nationalistic tendencies, and the lack of public acceptance toward virus sharing, need to be addressed to maximize the region’s collaboration potential in virology research. We recommend the governments to 1) prioritize the strengthening of research capacities; 2) develop stronger cooperation and possible centralization of efforts on top of national capacities; 3) develop an equitable and secure research framework; and 4) improve the public awareness regarding the importance of regional public health responses.